Taro Kanaya

3.3k total citations
40 papers, 2.8k citations indexed

About

Taro Kanaya is a scholar working on Physiology, Molecular Biology and Genetics. According to data from OpenAlex, Taro Kanaya has authored 40 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Physiology, 17 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Taro Kanaya's work include Telomeres, Telomerase, and Senescence (23 papers), Cancer Research and Treatments (9 papers) and Virus-based gene therapy research (5 papers). Taro Kanaya is often cited by papers focused on Telomeres, Telomerase, and Senescence (23 papers), Cancer Research and Treatments (9 papers) and Virus-based gene therapy research (5 papers). Taro Kanaya collaborates with scholars based in Japan and United States. Taro Kanaya's co-authors include Satoru Kyo, Masakí Inoue, Masahiro Takakura, Masaaki Tanaka, Yoshiko Maida, Mitsuhiro Nakamura, S Kyo, Noriyuki Yatabe, Masaki Inoue and Mitsuru Tanaka and has published in prestigious journals such as Cancer Research, Oncogene and Journal of Virology.

In The Last Decade

Taro Kanaya

36 papers receiving 2.8k citations

Peers

Countries citing papers authored by Taro Kanaya

Since Specialization

Citations

This map shows the geographic impact of Taro Kanaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taro Kanaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taro Kanaya more than expected).

Fields of papers citing papers by Taro Kanaya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taro Kanaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taro Kanaya. The network helps show where Taro Kanaya may publish in the future.

Co-authorship network of co-authors of Taro Kanaya

This figure shows the co-authorship network connecting the top 25 collaborators of Taro Kanaya. A scholar is included among the top collaborators of Taro Kanaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taro Kanaya. Taro Kanaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Menstrual toxic shock syndrome 2022 ·Canadian Medical Association Journal ·Takuya Seike, Taro Kanaya, (unknown)	1
2	Small bowel obstruction caused by intrauterine device infection 2021 ·Clinical Journal of Gastroenterology ·Takuya Seike, Taro Kanaya, (unknown), Naoki Oishi	0
3	Pharmacokinetics of Paclitaxel in Ovarian Cancer Patients and Genetic Polymorphisms of CYP2C8, CYP3A4, and MDR1 2005 ·The Journal of Clinical Pharmacology ·Miki Nakajima, Yuto Fujiki, Satoru Kyo, Taro Kanaya, Mitsuhiro Nakamura, Yoshiko Maida, Masaaki Tanaka, Masakí Inoue, Tsuyoshi Yokoi	64
4	Efficient Inhibition of Human Telomerase Reverse Transcriptase Expression by RNA Interference Sensitizes Cancer Cells to Ionizing Radiation and Chemotherapy 2005 ·Human Gene Therapy ·Mitsuhiro Nakamura, Kenkichi Masutomi, Satoru Kyo, Manabu Hashimoto, Yoshiko Maida, Taro Kanaya, Masaaki Tanaka, William C. Hahn, Masakí Inoue	6
5	Successful Immortalization of Endometrial Glandular Cells with Normal Structural and Functional Characteristics 2003 ·American Journal Of Pathology ·Satoru Kyo, Mitsuhiro Nakamura, Tohru Kiyono, Yoshiko Maida, Taro Kanaya, Masaaki Tanaka, Noriyuki Yatabe, Masaki Inoue	145
6	hTERT-promoter-based tumor-specific expression of MCP-1 effectively sensitizes cervical cancer cells to a low dose of cisplatin 2003 ·Cancer Gene Therapy ·Mitsuhiro Nakamura, Satoru Kyo, Taro Kanaya, Noriyuki Yatabe, Yoshiko Maida, Masaaki Tanaka, Yuko Ishida, Chifumi Fujii, Toshikazu Kondo, Masaki Inoue, Naofumi Mukaida	10
7	Significance of Immunological Detection of Human Telomerase Reverse Transcriptase 2003 ·American Journal Of Pathology ·Satoru Kyo, Kenkichi Masutomi, Yoshiko Maida, Taro Kanaya, Noriyuki Yatabe, Mitsuhiro Nakamura, Masaaki Tanaka, (unknown), Isamu Sugawara, Seishi Murakami, Takahiro Taira, Masakí Inoue	65
8	Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers 2003 ·Oncogene ·Taro Kanaya, Satoru Kyo, Yoshiko Maida, Noriyuki Yatabe, Masaaki Tanaka, Mitsuhiro Nakamura, Masakí Inoue	69
9	2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells 2002 ·Cancer Gene Therapy ·Noriyuki Yatabe, Satoru Kyo, Seiji Kondo, Taro Kanaya, Zhuo Wang, Yoshiko Maida, Masahiro Takakura, Mitsuhiro Nakamura, Masaaki Tanaka, Masakí Inoue	37
10	Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway 2002 ·Oncogene ·Yoshiko Maida, Satoru Kyo, Taro Kanaya, Zhuo Wang, Noriyuki Yatabe, Masaaki Tanaka, Mitsuhiro Nakamura, Masahide Ohmichi, Noriko Gotoh, Seishi Murakami, Masakí Inoue	121
11	Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells 2002 ·Oncogene ·Zhuo Wang, Satoru Kyo, Yoshiko Maida, Masahiro Takakura, Masaaki Tanaka, Noriyuki Yatabe, Taro Kanaya, Mitsuhiro Nakamura, Koji Koike, Koji Hisamoto, Masahide Ohmichi, Masakí Inoue	44
12	Is the telomerase assay useful for screening of endometrial lesions? 2002 ·International Journal of Cancer ·Yoshiko Maida, Satoru Kyo, Taro Kanaya, Zhuo Wang, Masaaki Tanaka, Noriyuki Yatabe, Mitsuhiro Nakamura, Masakí Inoue	11
13	A Case of Cervical Cancer with Aggressive Tumor Growth: Possible Autocrine Growth Stimulation by G-CSF and Il-6 2000 ·Gynecologic Oncology ·Satoru Kyo, Taro Kanaya, Masahiro Takakura, Masakí Inoue	66
14	Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors 1999 ·International Journal of Cancer ·Satoru Kyo, Taro Kanaya, Masahiro Takakura, Masaaki Tanaka, Atsuko Yamashita, Hirokazu Inoue, Masaki Inoue	80
15	Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues 1999 ·International Journal of Cancer ·Satoru Kyo, Taro Kanaya, Masahiro Takakura, Masaaki Tanaka, Masakí Inoue	103
16	hTERT is a critical determinant of telomerase activity in renal-cell carcinoma 1998 ·International Journal of Cancer ·Taro Kanaya, Satoru Kyo, Masahiro Takakura, Hideaki Ito, Mikio Namiki, Masaki Inoue	95
17	Ovarian Endometrioid Adenocarcinoma with Ectopic Production of α-Fetoprotein 1998 ·Gynecologic Oncology ·Yoshiko Maida, Satoru Kyo, Masahiro Takakura, Taro Kanaya, Masaki Inoue	14
18	Expression of Telomerase Activity in Human Endometrium Is Localized to Epithelial Glandular Cells and Regulated in a Menstrual Phase-Dependent Manner Correlated with Cell Proliferation 1998 ·American Journal Of Pathology ·Masaaki Tanaka, S Kyo, (unknown), Taro Kanaya, (unknown), Kaname Yamashita, Yasunori Okada, Eiso Hiyama, Masaki Inoue	74
19	Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. 1998 ·PubMed ·(unknown), S Kyo, Taro Kanaya, Mitsuru Tanaka, Masakí Inoue	274
20	The 5′ Region of the Human Papillomavirus Type 31 Upstream Regulatory Region Acts as an Enhancer Which Augments Viral Early Expression Through the Action of YY1 1997 ·Virology ·Taro Kanaya, Satoru Kyo, Laimonis A. Laimins	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact